What mediates the benefits associated with dipeptidyl peptidase-IV inhibition?-Reference-Cited by-同舟云学术

What mediates the benefits associated with dipeptidyl peptidase-IV inhibition?

Published:2005-03-16 Issue:4 Volume:48 Page:605-607
ISSN:0012-186X
Container-title:Diabetologia
language:en
Short-container-title:Diabetologia

Author:

Ahr�n B.

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00125-005-1706-6.pdf

Reference27 articles.

1. Deacon CF, Ahrén B, Holst JJ (2004) Inhibitors of dipeptidyl peptidase IV: a novel approach for the prevention and treatment of type 2 diabetes? Expert Opin Investig Drugs 13:1091?1102

2. Holst JJ, Gromada J (2004) Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans. Am J Physiol 287:E199?E206

3. Gutniak M, Ørskov C, Holst JJ, Ahrén B, Efendic S (1992) Antidiabetogenic effect of glucagon-like peptide-1 (7?36)amide in normal subjects and patients with diabetes mellitus. N Engl J Med 326:1316?1322

4. Zander M, Madsbad S, Madsen JL, Holst JJ (2002) Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and ?-cell function in type 2 diabetes: a parallel-group study. Lancet 359:824?830

5. Mentlein T, Gallwitz B, Schmidt WE (1993) Dipeptidyl peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1 (7?36)amide, peptide histidine methionine and is responsible for their degradation in human serum. Eur J Biochem 214:829?835

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Insight into the Development of Potential Antidiabetic Agents along with their Therapeutic Targets;Endocrine, Metabolic & Immune Disorders - Drug Targets;2024-01

2. Current Strategies and Drug Targets in the Management of Type 2 Diabetes Mellitus;Current Drug Targets;2018-10-26

3. Diabetes, hypertension, and chronic kidney disease progression: role of DPP4;American Journal of Physiology-Renal Physiology;2017-04-01

4. Impact of Sitagliptin on Markers of β-cell Function: A Meta-Analysis;The American Journal of the Medical Sciences;2009-05

5. Role of Pituitary Adenylate Cyclase-Activating Polypeptide in the Pancreatic Endocrine System;Annals of the New York Academy of Sciences;2008-11